This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE — It is not known whether glycemic instability may confer a risk of microvas-cular complications that is in addition to that predicted by the mean blood glucose (MBG) value alone. This study has analyzed data from the Diabetes Control and Complications Trial (DCCT) to assess the effect of glucose variability on the risk of retinopathy and nephropathy in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS — Pre- and postprandial seven-point glucose profiles were collected quarterly during the DCCT in 1,441 individuals. The mean area under the curve glucose and the SD of glucose variability within 24 h and between visits were compared with the risk of retinopathy and nephropathy, having adjusted for age, sex, disease duration, treatment group, prevention cohort, and phase of treatment. RESULTS — Multivariate Cox regression showed that within-day and between-day variability in blood glucose around a patient’s mean value has no influence on the development or pro-gression of either retinopathy (P 0.18 and P 0.72, respectively) or nephropathy (P 0.32 and P 0.57). Neither preprandial (P 0.18) nor postprandial (P 0.31) glucose concentra-tions preferentially contribute to the probability of retinopathy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kilpatrick et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: